KCM
Knoll Capital Management’s Applied Therapeutics APLT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Hold |
7,799,687
| – | – | 1.72% | 18 |
|
|
2025
Q1 | $3.81M | Buy |
7,799,687
+2,000,000
| +34% | +$976K | 2.48% | 14 |
|
|
2024
Q4 | $4.96M | Buy |
5,799,687
+225,000
| +4% | +$193K | 3.2% | 10 |
|
|
2024
Q3 | $47.4M | Hold |
5,574,687
| – | – | 21.96% | 1 |
|
|
2024
Q2 | $26M | Hold |
5,574,687
| – | – | 17.54% | 1 |
|
|
2024
Q1 | $37.9M | Buy |
5,574,687
+100,000
| +2% | +$680K | 23.58% | 1 |
|
|
2023
Q4 | $18.3M | Buy |
5,474,687
+312,599
| +6% | +$1.05M | 15.19% | 3 |
|
|
2023
Q3 | $12.9M | Buy |
5,162,088
+1,712,088
| +50% | +$4.26M | 13.34% | 2 |
|
|
2023
Q2 | $4.42M | Hold |
3,450,000
| – | – | 5.35% | 5 |
|
|
2023
Q1 | $2.8M | Buy |
3,450,000
+1,000,000
| +41% | +$811K | 4.31% | 6 |
|
|
2022
Q4 | $1.86M | Buy |
2,450,000
+1,367,877
| +126% | +$1.04M | 4.2% | 8 |
|
|
2022
Q3 | $1.01M | Hold |
1,082,123
| – | – | 0.59% | 10 |
|
|
2022
Q2 | $1.03M | Hold |
1,082,123
| – | – | 0.59% | 15 |
|
|
2022
Q1 | $2.28M | Buy |
1,082,123
+50,000
| +5% | +$105K | 1.43% | 8 |
|
|
2021
Q4 | $9.24M | Hold |
1,032,123
| – | – | 5.08% | 2 |
|
|
2021
Q3 | $17.1M | Hold |
1,032,123
| – | – | 8.54% | 2 |
|
|
2021
Q2 | $21.4M | Buy |
1,032,123
+6,659
| +0.6% | +$138K | 11.2% | 2 |
|
|
2021
Q1 | $19.2M | Buy |
1,025,464
+173,913
| +20% | +$3.26M | 12.53% | 2 |
|
|
2020
Q4 | $18.8M | Buy |
851,551
+116,571
| +16% | +$2.57M | 12.78% | 2 |
|
|
2020
Q3 | $15.3M | Buy |
734,980
+84,742
| +13% | +$1.76M | 12.5% | 2 |
|
|
2020
Q2 | $23M | Buy |
650,238
+8,167
| +1% | +$289K | 13.27% | 3 |
|
|
2020
Q1 | $21M | Buy |
642,071
+175,000
| +37% | +$5.72M | 19.72% | 3 |
|
|
2019
Q4 | $12.7M | Hold |
467,071
| – | – | 9.41% | 3 |
|
|
2019
Q3 | $5.13M | Hold |
467,071
| – | – | 4.7% | 5 |
|
|
2019
Q2 | $3.85M | Buy |
+467,071
| New | +$3.85M | 3.15% | 7 |
|